Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma

Olga Shakhova1, Phil Cheng2, Pravin J Mishra3

  • 1Cell and Developmental Biology, Institute of Anatomy, University of Zurich, Zurich, Switzerland.

Plos Genetics
|January 29, 2015
PubMed

Insights

The transcription factor SOX10 promotes melanoma, while SOX9 suppresses it. SOX9 upregulation upon SOX10 loss creates a feedback loop, revealing SOX10 and SOX9 as antagonistic melanoma regulators.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Melanoma, a fatal skin cancer, has poorly understood etiology.
  • The transcription factor SOX10 promotes melanoma initiation and progression.
  • Reducing SOX10 expression halts melanoma tumorigenesis by inducing cell cycle exit and apoptosis.

Purpose of the Study:

  • Investigate the role of SOX9 in the anti-tumorigenic effects of SOX10 reduction in melanoma.
  • Elucidate the functional relationship between SOX10 and SOX9 in melanoma development.

Main Methods:

  • Studied SOX9 expression and function in human melanoma cells and a genetic mouse model.
  • Analyzed cell cycle, apoptosis, and gene expression profiles upon SOX9 manipulation.
  • Investigated SOX9 binding to the SOX10 promoter and its effect on SOX10 expression.
  • Assessed the necessity of SOX9 for SOX10-low mediated anti-tumorigenic effects.

Main Results:

  • SOX9 is upregulated upon SOX10 loss and induces cell cycle arrest and apoptosis, similar to SOX10-low melanoma cells.
  • SOX9 binds to the SOX10 promoter, downregulating SOX10 expression and creating a reinforcing feedback loop.
  • SOX9 is essential for the anti-tumorigenic effects observed when SOX10 expression is reduced.
  • Unlike SOX10, SOX9 is not required for normal melanocyte stem cell function or melanoma initiation.

Conclusions:

  • SOX10 and SOX9 act as functionally antagonistic regulators in melanoma development.
  • The SOX10 low/SOX9 high state represents an anti-tumorigenic program.
  • Targeting this SOX10/SOX9 antagonism could offer novel therapeutic strategies for melanoma.

Related Concept Videos

Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
44.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K